Aeolus Pharmaceuticals, Inc.
AOLS
$0.0001
$0.000.00%
OTC PK
| 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | 06/30/2016 | |
|---|---|---|---|---|---|
| Net Income | -37.89% | -39.51% | -21.90% | -35.39% | -9.19% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -95.60% | -95.60% | -95.60% | -- | -- |
| Total Other Non-Cash Items | -- | 1,457.14% | 202.56% | -21.67% | -100.00% |
| Change in Net Operating Assets | 155.11% | 212.16% | -114.63% | 360.00% | -205.98% |
| Cash from Operations | 12.45% | -20.45% | -61.83% | -27.26% | -218.90% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | -100.00% | 9,925.00% | 481.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -91.96% | -91.96% | -91.96% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -100.00% | -100.00% | 504.90% | 1,978.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.39% | -182.80% | -171.02% | 315.11% | 490.19% |